BCL2 and breast carcinoma: Cases with high Bcl-2 have a higher overall survival rate compared to cases with low Bcl-2 (log-rank p = 0.0478) (Figure 6A) and breast cancer-specific survival (log-rank p = 0.0025) (Figure 6D).